Anti-thymocyte globulin(ATG) could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory peripheral T-cell lymphoma

被引：0
|
作者：
Jun, Y. [1 ]
Chun, W. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 1, Hematol, Shanghai 200030, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB161
引用
收藏
页码：5624 / 5624
页数：1
相关论文
共 50 条
  • [41] Variable clearance of anti-thymocyte globulin (ATG) following CD34 selected allogeneic hematopoietic progenitor cell transplantation (HPCT).
    Kakhniashvili, I
    Filicko, J
    McGuire, L
    Brunner, J
    Ferber, A
    Grosso, D
    Mookerjee, B
    Stout, N
    Wagner, JL
    Zhu, ZG
    Flomenberg, N
    BLOOD, 2002, 100 (11) : 839A - 839A
  • [42] Improved outcome of adult T-cell leukemia/lymphoma by allogeneic hematopoietic stem cell transplantation
    Utsunomiya, A
    Takatsuka, Y
    Takeuchi, S
    Hanada, S
    Uozumi, K
    Yashiki, S
    Sonoda, S
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 : S28 - S28
  • [43] Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis
    Yang, Xue
    Li, Dongjun
    Xie, Yao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept
    Meesters-Ensing, J. I.
    Admiraal, R.
    Ebskamp, L.
    Lacna, A.
    Boelens, J. J.
    Lindemans, C. A.
    Nierkens, S.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] Subsequent Hematopoietic Stem Cell Transplantation in Belinostat-Treated Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
    Shustov, Andrei R.
    Al-Ali, Haifa Kathrin
    Wulf, Gerald
    Hsu, Pamela
    Choi, Mi Rim
    Allen, Lee F.
    Visser, Otto J.
    Zachee, Pierre
    Horwitz, Steven M.
    BLOOD, 2014, 124 (21)
  • [46] Allogeneic stem cell transplantation as treatment for relapsed and high-risk peripheral T-cell lymphoma
    O'Leary, Hilary M.
    Savage, Kerry J.
    Toze, Cynthia L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Abou Mourad, Yasser
    Barnett, Michael J.
    Forrest, Donna L.
    Hogge, Donna E.
    Lavoie, Julye
    Nantel, Stephen H.
    Nevill, Thomas J.
    Shepherd, John D.
    Smith, Clayton
    Sutherland, Heather J.
    Voss, Nicholas
    Brinkmann, Ryan
    Song, Kevin
    BLOOD, 2007, 110 (11) : 893A - 893A
  • [47] ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMAS
    Na, Jihyun
    Kim, Juhyung
    Cho, Hee Jeong
    Ham, Ji Yeon
    Chang, Soon Hee
    Do, Young Rok
    Yea, Ji Woon
    Moon, Joon Ho
    Sohn, Sang Kyun
    Baek, Dong Won
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 347 - 347
  • [48] Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma
    Xiao, Zhengrui
    Li, Jianyong
    Miao, Kourong
    CURRENT STEM CELL RESEARCH & THERAPY, 2017, 12 (01) : 14 - 18
  • [49] Outcome of myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation for refractory/relapsed AML patients in NR status
    Liu, Na
    Ning, Hong-Mei
    Hu, Liang-ding
    Jiang, Min
    Xu, Chen
    Hu, Jiang-Wei
    Wang, Jun
    Li, Yu-Hang
    Li, Bo-tao
    Lou, Xiao
    Yang, Fan
    Chen, Jian-Lin
    Su, Yong-Feng
    Li, Meng
    Wang, Hong-ye
    Ren, Jing
    Feng, Yue-Qian
    Zhang, Bin
    Wang, Dan-hong
    Chen, Hu
    LEUKEMIA RESEARCH, 2015, 39 (12) : 1375 - 1381
  • [50] Peripheral T-cell lymphoma: The role of hematopoietic stem cell transplantation
    Gkotzamanidou, Maria
    Papadimitriou, Christos A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (02) : 248 - 261
12345